In today’s era of unprecedented opportunity and complexity within personalized medicine, it has become critical for innovators in the space to adopt a collaborative approach with outside experts in order to quickly and affordably bring new products and services to market. And, as it turns out, collaboration may also be the key to achieving mainstream clinical adoption.
The 4th Annual Business of Personalized Medicine Summit will examine in depth the financial-, regulatory-, policy-, R&D-, and technology-related challenges, trends, and opportunities impacting the marketplace and the future of health care by highlighting some of the innovative partnering and collaboration taking place throughout the industry. Join top executives from across multiple stakeholder perspectives to explore strategies for capitalizing on this challenging yet profitable market, plus solutions for advancing the field.
Summit co-host, the Personalized Medicine Coalition, will set the tone for the day with introductory remarks entitled, “Pioneering Precision: Industry’s Move Toward a Targeted Era.” PMC will present quantitative data on the status of industry’s efforts in personalized medicine and an analysis of the challenges to continued progress. The talk will illustrate, among other trends, the impressive pace at which new personalized medicines are reaching the marketplace.
SETTING THE STAGE: An inside look at recent trends and outcomes in personalized medicine investments and joint ventures, plus a forecast for future innovation and funding in the space
Featuring Nick Naclerio, PhD, Founder & Managing Partner, Illumina Ventures
BEHIND THE SCENES: An exclusive look at the formation of dRx Capital AG and the strategy behind the Novartis and Qualcomm digital/pharma collaboration
Featuring Lucian Iancovici, MD, and Aaron Nelson, MD, PhD, General Partners, dRx Capital AG, a Novartis and Qualcomm Joint Investment Company
In addition to all sessions, program materials, lunch, and the closing reception, this year’s Summit registration includes access to the California Technology Council’s First Pitch: Personalized Medicine demo day, which will involve presentations by Seed to Series A stage startups, investors, and researchers with genomics, diagnostics, and tool concepts at pre-commercial stages.
For more information, please visit PersonalizedMedicineSummit.com.
For questions, please contact Allison Jones at email@example.com.